Single Nucleotide Polymorphism Genotyping Market Global Industry Analysis & Forecast 2018-2028: Pharmaceutical Development Accelerates SNP Genotyping Utilization

Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Single Nucleotide Polymorphism Genotyping Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to's offering.

The global landscape for Single Nucleotide Polymorphism (SNP) Genotyping has been analyzed and is expected to exhibit remarkable growth, with a projected Compound Annual Growth Rate of 17.20% through 2028. At the forefront of genetic analysis, SNP Genotyping holds critical importance in various sectors, including healthcare, pharmaceuticals, and biotechnology.

In the period spanning from 2018-2028, the market valuation is set to surge from a calculated USD 8.15 billion to an impressive USD 20.97 billion by the end of the forecast period. SNP Genotyping, a fundamental technique in molecular biology, stands as a key facilitator in the detection and analysis of single nucleotide polymorphisms — the most common genetic variations within DNA sequences.

Technological Innovation Driving the SNP Genotyping Market

Advancements in genotyping technologies, such as high-throughput Next-Generation Sequencing (NGS) and DNA microarrays, are critical factors propelling the SNP Genotyping Market. The adoption of these technologies significantly enhances the efficiency and scalability of genetic analysis.

  • Automation and robust bioinformatics tools have become central, improving the precision and interpretation of massive genotyping data sets.
  • Digital PCR and Mass Spectrometry-based genotyping methods redefine the standards of accuracy, offering elevated throughput for genome-wide association studies (GWAS).
  • Technological strides in nanotechnology, and cutting-edge platforms like the CRISPR-Cas system, have the potential to revolutionary advance SNP genotyping capabilities, particularly in precision medicine.

Crucial Sectors Amplifying the Demand for SNP Genotyping

Forensic science, pharmacogenomics, and ancestry testing constitute major sectors contributing significantly to the market expansion. SNP Genotyping plays a pivotal role in these domains, ranging from the development of personalized medication regimens to elucidating complex genealogical histories.

  • In forensic applications, SNP Genotyping is essential for sensitive identification processes in criminal investigations and historical explorations.
  • Ancestry testing services leverage SNP analyses to satiate the growing public curiosity regarding genetic heritage, exploiting large SNP reference databases for precise ancestral mapping.

Pharmaceutical Development Accelerates SNP Genotyping Utilization

The pharmaceutical sector has shown an increasing dependency on SNP genotyping for drug discovery, patient stratification in clinical trials, and the development of companion diagnostics. This reliance underlines the significance of SNP Genotyping in the emergence of targeted therapies and the implementation of pharmacogenomics, tailoring treatments to genetic profiles for improved healthcare outcomes.

Geographical Market Insights

North America maintains its dominance in the SNP Genotyping Market, largely attributable to its robust biotechnological and pharmaceutical landscape, extensive research and development initiatives, and the presence of leading genotyping technology providers.

Challenges for the Global SNP Genotyping Market

While the SNP Genotyping Market is on a trajectory of considerable growth, it does face certain challenges:

  • High costs associated with advanced genotyping equipment and the need for specialized bioinformatics support might impede access, especially in under-resourced settings.
  • The vast complexity of genetic variations necessitates extensive data sets and complex analyses, which can present interpretational challenges.

With a lens on emerging trends, the report covers a comprehensive scope, including technological, application, and regional market insights that underscore the dynamic nature of SNP Genotyping. Through strategic market segmentation analysis, the report sheds light on potential growth opportunities and offers a profound understanding of this evolving market landscape.

The pivotal role of SNP Genotyping in agricultural biotechnology also garners attention, illustrating its implementation in crop and livestock improvement initiatives - a clear indicator of its wider impact across varied industries.

Key Attributes:

Report AttributeDetails
No. of Pages182
Forecast Period2022 - 2028
Estimated Market Value (USD) in 2022$8.15 Billion
Forecasted Market Value (USD) by 2028$20.97 Billion
Compound Annual Growth Rate17.2%
Regions CoveredGlobal

Companies Profiled:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Douglas Scientific
  • Illumina Inc.
  • Life Technologies Corp.
  • Luminex Corp
  • Promega Corporation
  • Thermo Fischer Scientific Inc.
  • Fluidigm Corporation

Report Scope

In this report, the Global Single Nucleotide Polymorphism Genotyping Market has been segmented into the following categories:

Single Nucleotide Polymorphism Genotyping Market, By Technology:

  • TaqMan SNP Genotyping
  • Massarray SNP Genotyping
  • SNP GeneChip Arrays
  • Others

Single Nucleotide Polymorphism Genotyping Market, By Application:

  • Animal Genetics
  • Plant Improvement
  • Diagnostic Research
  • Pharmaceuticals and Pharmacogenomics
  • Agricultural Biotechnology
  • Others

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Single Nucleotide Polymorphism Genotyping Market